Corrigendum to "Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice".

[This corrects the article DOI: 10.1155/2016/1405924.].

In the article titled “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice” [1], in Figure 3(c)(A), the value of ordinate should be narrowed down to 0.01 times that of the data presented. And in Figure 6(b), the abscissa p-65/p65 should be changed to p-p65/p65. The two corrected figures are presented here.